Chiniara Ellen 4
4 · Kymera Therapeutics, Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Chiniara Ellen
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-03+225,000→ 225,000 totalExercise: $24.84Exp: 2033-01-02→ Common Stock (225,000 underlying) - Award
Common Stock
2023-01-03+37,500→ 37,500 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following January 3, 2023, subject to the reporting person's continued employment through each vesting date.
- [F2]25% of the shares underlying this stock option shall vest on January 3, 2024, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the reporting person's continued employment through each vesting date.